CMN568/ CMN 568 (Latest 2023/ 2024) Intro to Family NP Unit 3 Exam Questions and Verified Answers| 100% Correct| Grade A

CMN568/ CMN 568 (Latest 2023/ 2024) Intro to Family NP Unit 3 Exam Questions and Verified Answers| 100% Correct| Grade A

CMN568/ CMN 568 (Latest 2023/ 2024) Intro
to Family NP Unit 3 Exam Questions and
Verified Answers| 100% Correct| Grade A
Q: A diagnosis of what should be considered for anyone with dyspnea, chronic cough or
sputum production, and exposure to cigarette smoking?
Answer:
COPD
Q: What diagnosic test is required to establish a diagnosis of COPD?
Answer:
spirometry
Q: What are the key indicators for considering a diagnosis of COPD?
Answer:
dyspnea (progressive, persistent, worsens with exercise), chronic cough, chronic sputum
production, hx. of exposure to cigarette smoke
Q: What FEV/FVC confirms the presence of persistent airflow limitation and thus COPD?
Answer:
<0.70
Q: What validated questionnaires are recommended for a comprehensive assessment of
symptoms associated with COPD?

Answer:
COPD assessment test (CAT) and Clinical COPD questionnaire (CCQ)
Q: What scale provides only an assessment of breathlessness?
Answer:
British Medical Research Council (mMRC) scale
Q: An exacerbation of COPD is defined as an acute event characterized by a worsening of
what?
Answer:
patient’s respiratory symptoms that is beyond normal day-to-day variations and leads to a change
in medication
Q: What is considered frequent exacerbations of COPD?
Answer:
2 or more per year
Q: What is the best predictor of having frequent exacerbations of COPD?
Answer:
a hx. of previous treated events
Q: What type of formulation of bronchodilators Is preferred in the treatment and management
of COPD?
Answer:

long acting
Q: Long term treatment with what is recommended for patients with severe airflow limitation
and for patients with frequent exacerbations that are not adequately controlled by
bronchodilators? Monotherapy not recommended however
Answer:
Inhaled corticosteroids
Q: What are the risks of long-term use of inhaled corticosteroids?
Answer:
pneumonia and increased risks of fractures
Q: What is the FEV1 in intermittent and mild asthma?
Answer:

80%
Q: What is the FEV1 in moderate asthma?
Answer:
<80%, but greater than 60%
Q: What is the FEV1 in severe asthma?
Answer:
<60%
Powered by https://learnexams.com/search/study?query=

Scroll to Top